fenofibric acid has been researched along with prostaglandin d2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dodo, K; Hashimoto, Y; Makishima, M; Sato, A; Sodeoka, M | 1 |
| Ikeda, M; Kakei, M; Matsumoto, S; Mori, M; Okada, S; Shimizu, H; Shimomura, K | 1 |
2 other study(ies) available for fenofibric acid and prostaglandin d2
| Article | Year |
|---|---|
Synthesis and evaluation of 2,3-dinorprostaglandins: Dinor-PGD1 and 13-epi-dinor-PGD1 are peroxisome proliferator-activated receptor α/γ dual agonists.
Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Conformation; PPAR alpha; PPAR gamma; Prostaglandins; Structure-Activity Relationship | 2013 |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
Topics: Animals; Chromans; Cricetinae; Fenofibrate; Immunologic Factors; Insulin; Insulin Secretion; Membrane Proteins; Potassium Channels; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2004 |